Drug Database
Back to search

Poland· PL-100087216

Arthrotec Forte

A diclofenac, kombinationen product containing diclofenacum + misoprostolum, registered in Poland by Pfizer Europe MA EEIG. The same ATC class is registered in 11 of our 19 countries.

ATC M01AB55

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedArthrotec ForteATCM01AB55REGISTER NO.PL-100087216PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about diclofenacum + misoprostolumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Diclofenac, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC M01AB55 (diclofenac, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search diclofenac, kombinationen products by name

Diclofenac, kombinationen · ATC M01AB55

11 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of diclofenac, kombinationen costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Diclofenac, kombinationen · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Diclofenacum + Misoprostolum
Manufacturer
Pfizer Europe MA EEIG
Country
Poland (PL)
ATC code
M01AB55
ATC class
Diclofenac, Kombinationen
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990422111
  • gtin
    05909990422128

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

68 interactions on record for diclofenac, kombinationen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check diclofenac, kombinationen against other medicinesHow interaction checks work

Diclofenac, kombinationen · interactions on record

68 records

68 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Diclofenac, kombinationen in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diclofenac, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Arthrotec, Arthrotec Forte
  • Belgium · Arthrotec
  • Germany · Arthotec Forte
  • Spain · Artrotec
  • Finland · Arthrotec Forte
  • United Kingdom (Northern Ireland) · Arthrotec
  • Ireland · Arthrotec
  • Italy · Artrotec
  • Luxembourg · Arthrotec
  • Netherlands · Arthrotec
  • Norway · Arthrotec
  • Portugal · Arthrotec, Diclofenac + Misoprostol Aurovitas
  • Romania · Arthrotec
  • Slovakia · Arthrotec Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c233dc9b-9e1d-4069-86c5-7547a33f67ae
GET /v1/drugs/c233dc9b-9e1d-4069-86c5-7547a33f67ae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "75 mg + 0,2 mg",
  "packaging": "05909990422111 ¦ Rp ¦ 13480\n10 tabl.\n05909990422128 ¦ Rp ¦ 13481\n20 tabl.",
  "substance": "Diclofenacum natricum 75 mg + Misoprostolum 0.2 mg",
  "common_name": "Diclofenacum + Misoprostolum",
  "pl_product_id": "100087216",
  "pozwolenie_nr": "04221",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about diclofenac, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console